热门资讯> 正文

InspireMD GAAP每股收益为-0.17美元

2025-11-04 20:29

InspireMD press release (NSPR): Q3 GAAP EPS of -$0.17.
As of September 30, 2025, cash and cash equivalents and marketable securities were $63.4 million compared to $34.6 million as of December 31, 2024.
U.S. revenue for the third quarter was $497,000 and international revenue was $2.0 million.

More on InspireMD

InspireMD Q3 2025 Earnings Preview
Seeking Alpha’s Quant Rating on InspireMD
Historical earnings data for InspireMD
Financial information for InspireMD

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。